Invivyd Inc. Common Stock (IVVD)
Fast GrowerFairStock Score: 62/100 — STEADY
Key Financials
| Current Price | $1.21 |
| Market Cap | $438M |
| P/E Ratio | -4.17 |
| ROE | -60.34% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Conservative balance sheet with debt-to-equity of just 0.01, providing financial flexibility
- Revenue growth of 24.5% demonstrates strong top-line momentum
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
AI Analysis
Invivyd Inc. Common Stock is a micro-cap healthcare company valued at $438 million. Revenue stands at $53 million, though the company is currently unprofitable. From a quality standpoint, Invivyd shows healthy Altman Z-Score of 3.4 and negative ROE indicating losses. Growth dynamics show revenue growing at 24.5% and profit growth of 40.0%. Our composite FairStock Score of 62/100 reflects above-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Invivyd's 25% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer